Home/Filings/4/0001927058-25-000002
4//SEC Filing

Mandel-Brehm Josh 4

Accession 0001927058-25-000002

CIK 0001736730other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:23 PM ET

Size

5.1 KB

Accession

0001927058-25-000002

Insider Transaction Report

Form 4
Period: 2025-09-11
Mandel-Brehm Josh
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.65/sh+6,060$9,999278,417 total
Footnotes (1)
  • [F1]On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

Entity typeother

Related Parties

1
  • filerCIK 0001927058

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:23 PM ET
Size
5.1 KB